CUE Financial Statements

Balance sheet, income statement, cash flow, and dividends for Cue Biopharma Inc (CUE).


$69.05M Market Cap.

As of 04/01/2025 5:00 PM ET (MRY) • Disclaimer

CUE Market Cap. (MRY)


CUE Shares Outstanding (MRY)


CUE Assets (MRY)


Total Assets

$32.19M

Total Liabilities

$14.69M

Total Investments

$0

CUE Income (MRY)


Revenue

$9.29M

Net Income

-$40.67M

Operating Expense

$50.79M

CUE Cash Flow (MRY)


CF Operations

-$36.33M

CF Investing

$32.00K

CF Financing

$10.24M

CUE Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CUE Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$32,191,000 (-47.68%)

$61,530,000 (-32.59%)

$91,283,000 (9.45%)

$83,400,935 (-16.21%)

Assets Current

$25,138,000 (-51.14%)

$51,454,000 (-33.34%)

$77,187,000 (12.73%)

$68,468,119 (-21.78%)

Assets Non-Current

$7,053,000 (-30.00%)

$10,076,000 (-28.52%)

$14,096,000 (-5.60%)

$14,932,816 (24.37%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$17,499,000 (-52.81%)

$37,085,000 (-43.54%)

$65,683,000 (0.29%)

$65,492,072 (-17.01%)

Property Plant & Equipment Net

$4,841,000 (-31.99%)

$7,118,000 (-33.49%)

$10,702,000 (-10.23%)

$11,921,825 (34.22%)

Cash & Equivalents

$22,611,000 (-55.97%)

$51,355,000 (-6.42%)

$54,880,000 (-18.38%)

$67,241,791 (-13.34%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

-$96,000 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$24,675,000 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$24,675,000 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$945,000 (-44.35%)

$1,698,000 (2878.95%)

$57,000 (-98.19%)

$3,142,527 (121.70%)

Trade & Non-Trade Payables

$2,823,000 (-19.37%)

$3,501,000 (28.19%)

$2,731,000 (5.42%)

$2,590,701 (25.14%)

Accumulated Retained Earnings (Deficit)

-$341,864,000 (-13.50%)

-$301,190,000 (-20.26%)

-$250,456,000 (-26.85%)

-$197,446,214 (-28.81%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$8,876,000 (-39.60%)

$14,695,000 (-23.92%)

$19,315,000 (92.13%)

$10,052,854 (40.67%)

Debt Current

$7,873,000 (7.39%)

$7,331,000 (39.29%)

$5,263,000 (6.72%)

$4,931,675 (3.23%)

Debt Non-Current

$1,003,000 (-86.38%)

$7,364,000 (-47.59%)

$14,052,000 (174.39%)

$5,121,179 (116.19%)

Total Liabilities

$14,692,000 (-39.90%)

$24,445,000 (-4.51%)

$25,600,000 (42.95%)

$17,908,863 (-13.16%)

Liabilities Current

$13,689,000 (-19.86%)

$17,081,000 (47.91%)

$11,548,000 (-9.69%)

$12,787,684 (-21.62%)

Liabilities Non-Current

$1,003,000 (-86.38%)

$7,364,000 (-47.59%)

$14,052,000 (174.39%)

$5,121,179 (18.92%)

CUE Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$9,287,000 (69.16%)

$5,490,000 (340.88%)

$1,245,227 (-91.67%)

$14,941,370 (373.68%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$14,585,000 (-12.56%)

$16,680,000 (3.16%)

$16,168,586 (-6.58%)

$17,306,678 (18.12%)

Research & Development Expense

$36,295,000 (-11.05%)

$40,802,000 (5.76%)

$38,578,083 (-6.70%)

$41,346,765 (23.26%)

Operating Expenses

$50,787,000 (-11.65%)

$57,482,000 (5.53%)

$54,470,036 (-7.13%)

$58,653,443 (21.70%)

Interest Expense

$796,000 (-36.06%)

$1,245,000 (74.41%)

$713,815 (0%)

$0 (0%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$495,000 (140.00%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$40,674,000 (19.83%)

-$50,733,000 (4.30%)

-$53,010,382 (-20.04%)

-$44,161,175 (1.39%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$40,674,000 (19.83%)

-$50,733,000 (4.30%)

-$53,010,382 (-20.04%)

-$44,161,175 (1.39%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$40,674,000 (19.83%)

-$50,733,000 (4.30%)

-$53,010,382 (-20.04%)

-$44,161,175 (1.39%)

Weighted Average Shares

$56,328,348 (23.11%)

$45,754,794 (28.35%)

$35,649,134 (13.95%)

$31,285,418 (9.05%)

Weighted Average Shares Diluted

$56,328,348 (23.11%)

$45,754,794 (28.35%)

$35,649,134 (13.95%)

$31,285,418 (9.05%)

Earning Before Interest & Taxes (EBIT)

-$39,878,000 (19.42%)

-$49,488,000 (5.37%)

-$52,296,567 (-19.76%)

-$43,666,175 (2.05%)

Gross Profit

$9,287,000 (69.16%)

$5,490,000 (340.88%)

$1,245,227 (-91.67%)

$14,941,370 (373.68%)

Operating Income

-$41,500,000 (20.18%)

-$51,992,000 (2.32%)

-$53,224,809 (-21.76%)

-$43,712,073 (2.95%)

CUE Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$32,000 (-99.87%)

$25,002,000 (201.59%)

-$24,609,877 (-370.19%)

$9,108,511 (104.42%)

Net Cash Flow from Financing

$10,243,000 (-13.63%)

$11,860,000 (-77.90%)

$53,659,133 (178.99%)

$19,233,322 (-67.19%)

Net Cash Flow from Operations

-$36,329,000 (9.09%)

-$39,961,000 (4.41%)

-$41,805,954 (-7.64%)

-$38,837,166 (-19.52%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$26,054,000 (-740.72%)

-$3,099,000 (75.71%)

-$12,756,698 (-21.55%)

-$10,495,333 (-134.33%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$25,000,000 (202.27%)

-$24,445,336 (-344.45%)

$10,000,000 (97.98%)

Capital Expenditure

$32,000 (1500.00%)

$2,000 (101.22%)

-$164,541 (81.54%)

-$891,489 (-49.76%)

Issuance (Repayment) of Debt Securities

-$3,999,000 (-99.95%)

-$2,000,000 (-120.29%)

$9,858,251 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$14,242,000 (2.76%)

$13,860,000 (-68.50%)

$44,000,755 (120.19%)

$19,983,450 (-66.06%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$6,846,000 (-16.31%)

$8,180,000 (-13.86%)

$9,495,876 (-17.54%)

$11,515,584 (9.87%)

Depreciation Amortization & Accretion

$2,350,000 (-31.61%)

$3,436,000 (272.58%)

$922,216 (-26.67%)

$1,257,662 (18.93%)

CUE Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-438.00% (52.60%)

-924.10% (78.29%)

-4257.10% (-1340.16%)

-295.60% (79.18%)

EBITDA Margin

-404.10% (51.82%)

-838.80% (79.67%)

-4125.70% (-1353.74%)

-283.80% (79.43%)

Return on Average Equity (ROAE)

-172.10% (-53.25%)

-112.30% (-27.61%)

-88.00% (-35.38%)

-65.00% (-5.86%)

Return on Average Assets (ROAA)

-93.90% (-32.07%)

-71.10% (-15.05%)

-61.80% (-19.08%)

-51.90% (-6.57%)

Return on Sales (ROS)

-429.40% (52.36%)

-901.40% (78.54%)

-4199.80% (-1336.81%)

-292.30% (79.32%)

Return on Invested Capital (ROIC)

-979.40% (-217.57%)

-308.40% (-123.64%)

-137.90% (89.31%)

-1290.10% (-615.93%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.51 (36.33%)

-2.38 (-24.31%)

-1.91 (76.15%)

-8.02 (-0.02%)

Price to Sales Ratio (P/S)

6.61 (-69.95%)

22 (-73.03%)

81.59 (244.53%)

23.68 (-79.19%)

Price to Book Ratio (P/B)

3.95 (22.85%)

3.21 (109.25%)

1.53 (-72.01%)

5.49 (14.27%)

Debt to Equity Ratio (D/E)

0.84 (27.47%)

0.66 (68.97%)

0.39 (42.86%)

0.27 (4.60%)

Earnings Per Share (EPS)

-0.72 (35.14%)

-1.11 (25.50%)

-1.49 (-5.67%)

-1.41 (9.62%)

Sales Per Share (SPS)

0.17 (37.50%)

0.12 (242.86%)

0.04 (-92.68%)

0.48 (334.55%)

Free Cash Flow Per Share (FCFPS)

-0.64 (26.23%)

-0.87 (25.83%)

-1.18 (7.32%)

-1.27 (-10.15%)

Book Value Per Share (BVPS)

0.31 (-61.65%)

0.81 (-55.97%)

1.84 (-11.99%)

2.09 (-23.92%)

Tangible Assets Book Value Per Share (TABVPS)

0.57 (-57.55%)

1.34 (-47.48%)

2.56 (-3.94%)

2.67 (-23.15%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (50.00%)

-2 (0.00%)

-2 (71.43%)

-7 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.15 (31.59%)

-1.69 (0.94%)

-1.7 (75.30%)

-6.9 (4.02%)

Asset Turnover

0.21 (177.92%)

0.08 (413.33%)

0.01 (-91.43%)

0.17 (414.71%)

Current Ratio

1.84 (-39.04%)

3.01 (-54.94%)

6.68 (24.84%)

5.35 (-0.21%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$36,297,000 (9.16%)

-$39,959,000 (4.79%)

-$41,970,495 (-5.64%)

-$39,728,655 (-20.06%)

Enterprise Value (EV)

$43,301,856 (-44.26%)

$77,684,462 (-11.19%)

$87,468,909 (-70.09%)

$292,447,299 (-6.47%)

Earnings Before Tax (EBT)

-$40,674,000 (19.83%)

-$50,733,000 (4.30%)

-$53,010,382 (-21.40%)

-$43,666,175 (2.05%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$37,528,000 (18.51%)

-$46,052,000 (10.36%)

-$51,374,351 (-21.14%)

-$42,408,513 (2.56%)

Invested Capital

$4,767,000 (-38.80%)

$7,789,000 (-82.37%)

$44,170,000 (229.03%)

$13,424,314 (5.08%)

Working Capital

$11,449,000 (-66.69%)

$34,373,000 (-47.63%)

$65,639,000 (17.89%)

$55,680,435 (-21.81%)

Tangible Asset Value

$32,191,000 (-47.68%)

$61,530,000 (-32.59%)

$91,283,000 (9.45%)

$83,400,935 (-16.21%)

Market Capitalization

$69,051,856 (-42.03%)

$119,125,462 (18.12%)

$100,848,909 (-71.93%)

$359,216,299 (-5.17%)

Average Equity

$23,631,250 (-47.71%)

$45,193,000 (-24.95%)

$60,219,000 (-11.31%)

$67,897,768 (-6.94%)

Average Assets

$43,320,250 (-39.26%)

$71,315,750 (-16.84%)

$85,759,000 (0.69%)

$85,167,234 (-7.47%)

Invested Capital Average

$4,071,750 (-74.62%)

$16,045,000 (-57.68%)

$37,910,750 (1020.02%)

$3,384,828 (-86.31%)

Shares

63,350,327 (40.39%)

45,123,281 (27.52%)

35,385,582 (11.41%)

31,760,946 (4.90%)